LSD1-Directed Therapy Affects Glioblastoma Tumorigenicity by Deregulating the Protective ATF4-Dependent Integrated Stress Response

Scientists found that lysine-specific histone demethylase 1 (LSD1) inhibition hampered the induction of the activating transcription factor 4, the master regulator of the integrated stress response.